Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Gastroenterology
•
General Hepatology
How do you choose between resmetirom and semaglutide in the treatment of MASH?
Related Questions
Do you avoid JAK inhibitors in patients with a history of liver disease including NAFLD or cirrhosis?
Which patients with cirrhosis and portal hypertension are ideal candidates to undergo TIPS to reduce perioperative risk in anticipation of an elective surgery?
How you do approach treatment for a patient with active seropositive RA (+RF/+CCP) who is receiving treatment for Hepatitis C?
Is there a risk of hepatitis C activation with rituximab in a patient who has a history of HCV treated with antivirals and who is in sustained viral response?
What pharmacologic therapies do you use to treat alcohol use disorder in a patient with cirrhosis?
Does hepatitis B vaccination reduce the risk of HBV reactivation associated with immunosuppressive therapy?
How would you manage a solitary unresectable liver metastasis?
How would you manage a patient with highly active ankylosing spondylitis, iritis and Crohn’s, controlled with weekly adalimumab with co-morbid IgG4RD and intolerance of azathioprine due to elevated LFTs?
Do you avoid terlipressin for patients with hepatorenal syndrome who have a serum sodium level less than 125 mEq/L?
What approaches can we take to initiate therapy and improve survival rates in patients with HLH?
